drugset / Trial / NCT01628029
Cognitive Behavioral Therapy and Multimodal Therapy in Treating Sleep Disturbance in Patients With Cancer
Phase 2
Active not recruiting
68 enrolled
M.D. Anderson Cancer Center
National Cancer Institute (NCI) · collab
RandomizedFactorialDouble-blindSupportive care
Summary
This randomized phase II trial studies how well cognitive behavioral therapy and multimodal therapy works in treating sleep disturbance in patients with cancer. Cognitive behavioral therapy may help reduce sleep disturbances, fatigue, and insomnia as well as improve the well-being and quality of life of patients with cancer when given together with methylphenidate hydrochloride, therapeutic melatonin, and light therapy.
Timeline
- Start
- 2014-01-15
- Primary completion
- 2025-12-22
- Completion
- 2028-12-31
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Melatonin | Small molecule | — | Oral |
| Subject | Methylphenidate | Small molecule | — | Oral |